Blood Culture Test Market Size to Hit USD 22.47 Billion by 2033

According to Nova One Advisor, the global blood culture Test market size was valued at USD 6.92 Billion in 2023 and is expected to grow from USD 7.79 Billion in 2024 to reach USD 22.47 billion by 2033, at a CAGR of 12.5% during the forecast period (2024-2033)

The Full Study is Readily Available | Download the Sample Pages of this Report@ ?https://www.novaoneadvisor.com/report/sample/5140

The increasing incidence of bloodstream infections as well as infectious diseases. Rising demand for advanced diagnostic techniques for the diagnosis of infectious diseases, such as sepsis, is also projected to drive growth. Recently, a substantial number of market players are focusing on the development of advanced tests with an aim to improve the efficiency of overall diagnostic procedures. Thus, many manufacturing companies are focusing on the development of advanced diagnostic instruments and consumables.

For instance, in May 2022, Cepheid confirmed that its Xpert Xpress CoV-2plus, a quick molecular diagnostic test for the identification of the infectious virus that causes COVID-19, has obtained the CE mark. Xpert Xpress CoV-2plus unites Xpert Xpress CoV-2/Flu/RSV plus as well as other PCRplus respiratory assessments in Cepheid’s diverse range of rapid, reliable, and implementable respiratory results. Such developments are likely to have a positive impact on the growth of the market during the forecast period. The introduction of various government initiatives pertaining to the prevention and control of infections is likely to propel the demand for blood culture tests.

Moreover, the authorities are also focusing on the implementation of strict guidelines to maintain the quality of diagnostics. For instance, in May 2022, CLSI released new National Blood Culture guidelines to prevent and reduce blood culture contaminations. Such regulations are also projected to accelerate the demand by 2033. A massive rise in the number of patients with COVID-19 infection throughout the world resulted in a significant increase in blood culture utilization, which greatly impacted the demand for automated instruments. For instance, in February 2022, Becton, Dickinson, and Company collaborated with ReturnSafe, an all-in-one software application for COVID-19 employee health, well-being, and adherence, to incorporate the BD Verito At-Home COVID-19 Test kits.

This consolidated solution, which uses the ReturnSafe and BD Veritor at-home COVID-19 Test, enables convenient and cost-effective administration of an enterprise's overall population. Key players are focusing on collaborations for the introduction of novel technologies. For instance, in September 2022, OpGen announced a strategic collaboration with FIND for rapid diagnosis of antimicrobial resistance (AMR) with the help of blood culture. Such developments are estimated to offer a favorable environment for market growth.

Immediate Delivery Available, Get Full Access@ https://www.novaoneadvisor.com/report/checkout/5140

??Blood Culture Test Market?Report Highlights

• The conventional technique segment captured the largest share of 64.78% in 2023 due to higher applications of this method in hospitals, individual clinical laboratories, as well as pathology laboratories
• The consumables segment accounted for the largest revenue share of 59.99% in 2023 owing to the increased adoption of blood culture tests across all the applications
• The automated systems segmentis anticipated to register the fastest CAGR from 2024 to 2033 owing to the increasing demand for technologically advanced diagnostic systems, improved accuracy, and minimal turn-around time
• The molecular technology segment is anticipated to grow at the highest CAGR over the forecast period owing to the high demand for innovative products by hospitals and laboratories for the diagnosis of infectious diseases
• The bacterial infections segment held the maximum share in 2023 owing to the high prevalence of bacterial infections and the adoption of these tests for bacterial disease diagnosis due to its proven success rate
• The reference laboratories segment is anticipated to grow at the highest CAGR during the forecast period as there is a rise in outsourcing of blood tests by hospitals to reference laboratories
• North America accounted for the highest revenue share of 45.0% in2023 owing to massive investments in research & development

Regional Insights

North America held the largest revenue share of 45.0% in 2023 attributable to a well-established clinical diagnostics industry, presence of several key players, availability of government-funded programs, reimbursement structure, awareness initiatives, and new product launches. For instance, in February 2023, BARDA received FDA Approval for the Selux NGP System in partnership with Selux Diagnostics, Inc. The system is designed to allow testing directly from positive blood cultures, which helps to reduce the total test time from 36 hours to 16 hours from whole blood collection.

Asia Pacific is anticipated to witness the highest CAGR during the forecast period owing to an increase in number of hospitalizations, and rising cases of various diseases such as urinary tract infections, bloodstream infections, & ventilator-associated pneumonia. Several key players are geographically expanding into Asian countries such as China and India due to high unmet needs, growing opportunities to gain a higher share in the market, and the presence of the target population.

Some of the prominent players in the Blood culture test market include:

• BD
• Terumo Corporation
• Bruker Corporation
• bioMerieux
• T2 Biosystems Inc.
• Luminex Corporation
• Abbott Laboratories
• Siemens Healthineers AG
• Danaher Corporation
• F. Hoffmann-La Roche Ltd

Immediate Delivery Available | Buy This Premium Research ?https://www.novaoneadvisor.com/report/checkout/5140

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the Blood Culture Test Market analysis from 2021 to 2033 to identify the prevailing Blood Culture Test Market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the cancer supportive care drugs industry segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global Blood Culture Test Market trends, key players, market segments, application areas, and market growth strategies.

Procure Complete Report (220+ Pages PDF with Insights, Charts, Tables, and Figures) @ ?https://www.novaoneadvisor.com/report/checkout/5140

Call: USA: +1 650 460 3308 | IND: +91 87933 22019 |Europe: +44 2080772818

Email: [email protected]

Web: https://www.novaoneadvisor.com/